FDA Import Refusal 799-4477512-1/11/1 — AbbVie Inc.
The FDA refused shipment 799-4477512-1/11/1 from AbbVie Inc. (United States) on April 20, 2023. The refused product falls under Drugs and Biologics — BOTOX. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- April 20, 2023
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 65QCY02 BOTOX
- Charges
- 118,3280